Sex-specific effects of estrogen and androgen on gene expression in human monocyte-derived osteoclasts
- 3 August 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 112 (12) , 3714-3721
Abstract
Estrogen and androgen are both critical for the maintenance of bone, but the target cells, mechanisms, and responses could be sex-specific. To compare sex-specific actions of estrogen and androgen on osteoclasts, human peripheral blood mononuclear precursor cells from adult Caucasian males (n = 3) and females (n = 3) were differentiated into osteoclasts and then treated for 24 h with 17β-estradiol (10 nM) or testosterone (10 nM). Gene expression was studied with a custom designed qPCR-based array containing 94 target genes related to bone and hormone action. In untreated osteoclasts, 4 genes showed significant gender differences. 17β-estradiol significantly affected 12 genes in osteoclasts from females and 6 genes in osteoclasts from males. Fifteen of the 18 17β-estradiol-responsive genes were different in the cells from the two sexes; 2 genes affected by 17β-estradiol in both sexes were regulated oppositely in the two sexes. Testosterone significantly affected 6 genes in osteoclasts from females and 2 genes in osteoclasts from males; all except one were different in the two sexes. 17β-estradiol and testosterone largely affected different genes, suggesting that conversion of testosterone to 17β-estradiol had a limited role in the responses. The findings indicate that although osteoclasts from both sexes respond to 17β-estradiol and testosterone, the effects of both 17β-estradiol and testosterone differ in the two sexes, highlighting the importance of considering gender in the design of therapy. J. Cell. Biochem. 112: 3714–3721, 2011.Keywords
This publication has 49 references indexed in Scilit:
- Sexually Dimorphic Actions of Glucocorticoids Provide a Link to Inflammatory Diseases with Gender Differences in PrevalenceScience Signaling, 2010
- Androgens and osteoporosisCurrent Opinion in Endocrinology, Diabetes and Obesity, 2010
- Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosisNature Medicine, 2009
- Tumor necrosis factor-alpha: Alternative role as an inhibitor of osteoclast formation in vitroBone, 2006
- Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifeneSteroids, 2005
- Genetic Polymorphisms of OPG, RANK, and ESR1 and Bone Mineral Density in Korean Postmenopausal WomenCalcified Tissue International, 2005
- Skeletal Effects of Cyclosporin A Are Gender Related in RatsEndocrinology, 2003
- Diminished Callus Size and Cartilage Synthesis in α1β1 Integrin-Deficient Mice during Bone Fracture HealingThe American Journal of Pathology, 2002
- Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by OsteoclastsJournal of Biological Chemistry, 2000
- Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK IsoformsScience, 1995